BRÈVE publiée le 28/01/2026 à 02:05, il y a 39 minutes Troy Minerals to Settle $348,000 Debt with Share Issuance Debt Settlement Financial Position Share Issuance Regulatory Approvals Canadian Securities
BRÈVE publiée le 28/01/2026 à 02:05, il y a 39 minutes Troy Minerals va régler une dette de 348 000 $ par une émission d'actions Émission D'actions Approbations Réglementaires Situation Financière Règlement De Dettes Valeurs Mobilières Canadiennes
COMMUNIQUÉ DE PRESSE publié le 28/01/2026 à 02:00, il y a 44 minutes Troy Minerals Announces Debt Settlement Troy Minerals Inc. plans to settle $348,000 debt by issuing 2,784,000 common shares at $0.125/share, improving financial position and preserving capital. Debt settlement subject to closing conditions and regulatory approvals Common Shares Debt Settlement Troy Minerals Inc. Financial Position Regulatory Approvals
BRÈVE publiée le 28/01/2026 à 01:05, il y a 1 heure 39 minutes Boron One Holdings Increases Private Placement Offer Private Placement TSX Venture Exchange Capital Raising Financial Update Boron One Holdings
BRÈVE publiée le 28/01/2026 à 01:05, il y a 1 heure 39 minutes Boron One Holdings augmente son offre de placement privé Placement Privé Bourse De Croissance TSX Mise À Jour Financière Boron One Holdings Levée De Capitaux
COMMUNIQUÉ DE PRESSE publié le 28/01/2026 à 01:00, il y a 1 heure 44 minutes Boron One Announces Increase to Private Placement Boron One Holdings Inc. increases non-brokered private placement by $100,000 to $600,000. Extension granted for required documentation filing. Proceeds for working capital Private Placement TSX Venture Exchange Mineral Exploration Working Capital Boron One
BRÈVE publiée le 27/01/2026 à 22:20, il y a 4 heures 24 minutes Biomind Labs Secures CAD $2.52 Million Through Private Placement Private Placement Toronto Neuroscience Biopharmaceuticals Biomind Labs
BRÈVE publiée le 27/01/2026 à 22:20, il y a 4 heures 24 minutes Biomind Labs lève 2,52 millions de dollars canadiens par placement privé Toronto Placement Privé Neuroscience Produits Biopharmaceutiques Laboratoires Biomind
COMMUNIQUÉ DE PRESSE publié le 27/01/2026 à 22:15, il y a 4 heures 29 minutes Biomind Labs Announces CAD $2.52 Million Private Placement Financing Biomind Labs Inc. launches a non-brokered private placement of up to 28,000,000 units at $0.09 per unit, aiming to raise up to C$2,520,000 for advancing clinical programs and working capital Private Placement Clinical Development Neuroscience Biomind Labs Inc. Pharmaceutical Drugs
BRÈVE publiée le 27/01/2026 à 20:25, il y a 6 heures 19 minutes FutureGen Industries Unaware of Market Activity Change Forward-looking Statements Investment Market Activity Venture Capital FutureGen Industries
Publié le 27/01/2026 à 19:00, il y a 7 heures 44 minutes MISE A DISPOSITION RAPPORT FINANCIER SEMESTRIEL 2025/2026
Publié le 27/01/2026 à 19:00, il y a 7 heures 44 minutes RAPPORT FINANCIER SEMESTRIEL 25/26 TFF GROUP
Publié le 27/01/2026 à 19:00, il y a 7 heures 44 minutes RAPPORT FINANCIER SEMESTRIEL 25/26 TFF GROUP
Publié le 27/01/2026 à 17:45, il y a 8 heures 59 minutes Imerys-27-01-2026-information-share-capital-and-voting-rights-as-of-31-December-2025
Publié le 28/01/2026 à 01:00, il y a 1 heure 44 minutes Boron One Announces Increase to Private Placement
Publié le 27/01/2026 à 22:15, il y a 4 heures 29 minutes Biomind Labs Announces CAD $2.52 Million Private Placement Financing
Publié le 27/01/2026 à 20:20, il y a 6 heures 24 minutes FutureGen Industries is Unaware of Any Material Change
Publié le 27/01/2026 à 19:30, il y a 7 heures 14 minutes Taranis Plans Modern Exploration Programs in Brownfield Silver Cup Mining District
Publié le 27/01/2026 à 20:19, il y a 6 heures 25 minutes Aroundtown SA announces successful €750 million perpetual notes issuance and tender offer launch
Publié le 27/01/2026 à 20:17, il y a 6 heures 27 minutes Aroundtown SA announces successful €750 million perpetual notes issuance and tender offer launch
Publié le 27/01/2026 à 19:16, il y a 7 heures 28 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 27/01/2026 à 18:05, il y a 8 heures 39 minutes New indication in children from birth for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission
Publié le 27/01/2026 à 18:00, il y a 8 heures 44 minutes GEVELOT S.A.: Weekly declaration of share buybacks – 26/01/2026
